---
$id: https://graph.org.ai/products/commodity/51332514
$type: Product
source: UNSPSC
code: "51332514"
title: "Trifluperidol"
class: "51332500"
classTitle: "Antipsychotic butyrophenones"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trifluperidol

**UNSPSC Code**: 51332514
**Class**: [Antipsychotic butyrophenones](Antipsychotic butyrophenones.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C22H23F4NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8869Q7R8I, chemically known as 4-fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino)butyrophenone but generally known as trifluperidol, which bears US NIH Compound Identifier 5567. European Medicines Agency schedules Trifluperidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11289MIG. The term TRIFLUPERIDOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules trifluperidol in its Anatomical Therapeutic Chemical (ATC) Classification. TRIFLUPERIDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trifluperidol under HS 29333999 and SITC 51574. As of Q4 2014, TRIFLUPERIDOL remains the US FDA Preferred Term for this commodity. Trifluperidol bears US NLM identifiers UMLS ID C0040988 and NCI Concept Code C76455. SMILES: FC(F)(F)C1CC(C2(O)CCN(CC2)CCCC(=O)C2CCC(F)CC2)CCC1.

